Stock APVO APTEVO THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Aptevo Therapeutics Inc.

Equities

APVO

US03835L3069

Market Closed - Nasdaq
Other stock markets
 03:59:50 2024-03-05 pm EST 		5-day change 1st Jan Change
5.694 USD -7.17% Intraday chart for Aptevo Therapeutics Inc. -13.10% -28.51%
Apr. 11 US Equity Markets Close Mixed After March Producer Price Inflation Data MT
Apr. 11 Top Midday Decliners MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Aptevo Therapeutics Announces Closing of $4.6 Million Public Offering
AQ
Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering
AQ
US Equity Markets Close Mixed After March Producer Price Inflation Data
MT
Top Midday Decliners
MT
Top Premarket Decliners
MT
Aptevo Therapeutics Inc. Provides Pipeline Update
CI
Alligator Bioscience and Aptevo Therapeutics Announce Positive Interim Data of Dose Escalation Phase of ALG.APV-527 Phase 1 Study in Solid Tumor Cancers Expressing Tumor Antigen 5T4
CI
Alligator Bioscience and Aptevo Therapeutics Announce Positive Interim Data of Dose Escalation Phase of ALG.APV-527 Phase 1 Study in Solid Tumor Cancers Expressing Tumor Antigen 5T4
AQ
Aptevo Therapeutics Reports 2023 Financial Results and Provides a Business Update
AQ
Aptevo Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Alligator Bioscience AB reports full year financial results for 2023 and for Q4 2023 and provides a business update
AQ
Aptevo Therapeutics Reports 3Q23 Financial Results and Provides a Business Update
AQ
Aptevo Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Certain Warrants of Aptevo Therapeutics Inc. are subject to a Lock-Up Agreement Ending on 3-NOV-2023.
CI
Certain Stock Options of Aptevo Therapeutics Inc. are subject to a Lock-Up Agreement Ending on 3-NOV-2023.
CI
Certain Common Stock of Aptevo Therapeutics Inc. are subject to a Lock-Up Agreement Ending on 3-NOV-2023.
CI
Aptevo to Present at Bio-Europe Conference
AQ
Aptevo Therapeutics : 28 August 2023 Investor Presentation
PU
Aptevo Therapeutics Reports 2Q23 Financial Results and Provides a Business Update
AQ
Aptevo Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. APVO Stock
  4. News Aptevo Therapeutics Inc.